Inhibikase Therapeutics, Inc. - Common Stock (IKT)

1.6700
+0.00 (0.00%)
NASDAQ· Last Trade: Jun 16th, 9:00 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors